NCT04417218View on ClinicalTrials.gov

Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 17, 2020

Primary Completion Date

January 1, 2023

Study Completion Date

January 1, 2023

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Lysine

Lysine is an essential amino acid which is acquired from dietary sources.

DIETARY_SUPPLEMENT

Controlled Diet

Individuals will be instructed to consume specific foods, to adhere to a controlled lysine diet.

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT04417218 - Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 2 | Biotech Hunter | Biotech Hunter